2m 2m 2m 2m 2m 2m 2m
LB PHARM (LBRX)
NASDAQ
$39.41+$0.18 (+0.46%)
Price as of Oct 22, 2026 7:30 PM EDT- $1.3BMarket Cap
- 149.71%1-Year Change
- BiotechnologyIndustry
LB PHARM (LBRX)
$39.41+$0.18 (+0.46%)
LBRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $39.23 | ||
Change | -$1.77 (-4.32%) | ||
Open | $41.10 | ||
High | $41.24 | ||
Low | $39.04 | ||
Previous Close | $41.00 | ||
Volume | 246,964 | ||
30-Day Average Volume | 464,092 | ||
1-Week Change | 15.38% | ||
1-Month Change | -8.75% | ||
1-Year Change | 149.71% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 32.3M | ||
Total Assets | $361.7M | ||
Market Cap | $1.3B | ||
Enterprise Value | $982.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$51.6M | ||
Free Cash Flow | -$38.0M | ||
EBIT | -$51.6M | ||
EBITDA | -$51.5M | ||
Net Working Capital | $331.7M | ||
EPS | -$1.71 | ||
Enterprise Value/EBITDA | -19 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -23 | ||
PEG | 0 | ||
Price/Free Cash Flow | -33 | ||
Price/Operating Cash Flow | -34 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue